Revel Pharmaceuticals-preview

Revelpharmaceuticals

Revel Pharmaceuticals

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://revelpharmaceuticals.com/

Last Round

Grant

Aug 15, 2023

Total Funding Raised

$8.95M

Momentum Score

75 /100

Company Overview

Revel Pharmaceuticals is a biotechnology company developing therapeutic enzymes designed to degrade molecular damage associated with aging.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

therapeutic enzymeslongevity biotechglucosepane breakerprotein crosslink breakerAdvanced Glycation End-productsAGEsenzyme engineeringage-related diseaseenzyme discovery platformmolecular damage repairgeroscienceanti-aging therapeuticstissue stiffeningpreclinical biopharmaSENS Research Foundation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Revel Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Revel Pharmaceuticals Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Aug 15, 2023
Seed	Mar 17, 2022
Seed	Jan 7, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Aaron Cravens

Chief Executive Officer

Executive Team

Revel Pharmaceuticals Investors

Notable investors and investment history

Investor	Rounds
Kizoo Technology Capital	Seed
Starbloom Capital	Seed
NIH RADx	Grant
Tubus LLC	Seed
National Institute on Aging	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 1, 2026
Monthly visitors increased 267% MoM.
Jun 1, 2025
Monthly visitors increased 71% MoM.

View all signals

Revel Pharmaceuticals Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Revel Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Revel Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range8

Year Founded2019

Last FundingAug 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.